Here's to Your Health
暂无分享,去创建一个
Xiaofei Wang | Todd A. Schwartz | Mark E. Glickman | Herbert Pang | M. Glickman | Xiaofei Wang | Herbert Pang | Todd A Schwartz
[1] Igor Jurisica,et al. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.
[2] R. Simon,et al. Designs and adaptive analysis plans for pivotal clinical trials of therapeutics and companion diagnostics. , 2008, Expert opinion on medical diagnostics.
[3] S. Mukherjee,et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. , 2006, The New England journal of medicine.
[4] R. Simon,et al. Evaluating the Efficiency of Targeted Designs for Randomized Clinical Trials , 2004, Clinical Cancer Research.
[5] S. Dudoit,et al. Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data , 2002 .
[6] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.
[7] T. Lumley,et al. Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.
[8] R. Prentice. Surrogate endpoints in clinical trials: definition and operational criteria. , 1989, Statistics in medicine.